How to Identify, Treat, and Manage Patients with Multiple Myeloma

 

How to Identify, Treat, and Manage Patients with Multiple Myeloma
05:27

ASH 2021 Conference Coverage on VuMedi

ASH 2021 Sustained Improvement in HRQoL in Transplant-Ineligible Patients With NDMM Treated With D-Rd vs. Rd: Update of the Phase 3 MAIA Trial

FEATURING Aurore Perrot
  • 74 views
  • February 26, 2022
08:55

Laurent Garderet

D-Rd in Transplant-Ineligible NDMM: Results From the MAIA Trial

  • 506 views
  • October 7, 2021
  • 2
16:16

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

Frontline Therapy for NDMM: The Role of Transplant, Duration & Goals of Maintenance Therapy, and QoL

FEATURING Amrita Krishnan
  • 73 views
  • September 30, 2021
15:16

SOHO 3rd Italian Conference

SOHO Italy 2021: Newly Diagnosed Transplant-Eligible MM

FEATURING Vittorio Montefusco
  • 37 views
  • January 4, 2022
09:07

ASH 2021 Conference Coverage on VuMedi

ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negativity in NDMM Patients Treated with D-KRd

FEATURING Eileen Boyle
  • 158 views
  • December 16, 2021
  • 1
19:15

Total Health

Treatment Updates for MM: Risk Stratification's Role in Upfront & Relapsed Setting, MRD and Bone Health

FEATURING Charise Gleason
  • 45 views
  • October 13, 2021
18:44

Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

Moffitt Cancer Center Debate: How Much Is Enough in NDMM - Triplet Therapy vs. Quadruplet Therapy

FEATURING Kenneth Shain
  • 150 views
  • February 14, 2022
  • 1
13:22

SOHO 3rd Italian Conference

SOHO Italy 2021 on the Importance of Imaging in Novel Agents' Era in MM

FEATURING Elena Zamagni
  • 6 views
  • December 23, 2021
06:03

UChicago Medicine 7th Annual Updates from ASH 2021

Post-ASH Case Discussion: 59 y/o Male With Blurry Vision and Developed Myeloma

FEATURING Sonali Smith, Michael Drazer
  • 58 views
  • March 11, 2022
19:18

Yale Cancer Center

2021 ASH Updates in Smoldering Myeloma and Newly Diagnosed MM

FEATURING Elan Gorshein
  • 33 views
  • March 23, 2022
07:15

Ola Landgren

Awareness Around MRD Testing in Myeloma: Why, When, and How to Test

  • 99 views
  • April 6, 2022
20:17

Rush University Medical Center

High-Risk Myeloma: Failures and Future Directions

FEATURING Saad Usmani
  • 71 views
  • May 27, 2022
20:58

Penn Medicine Abramson Cancer Center

Initial Therapy for MM Including Transplant

FEATURING Alfred Garfall
  • 50 views
  • May 2, 2022
04:29

ecancer

EHA 2022 on a Phase III GMMG-HD7 Trial: Isa-RVd as Induction Therapy for NDMM Patients

FEATURING Elias Mai
  • 93 views
  • June 21, 2022
  • 1
31:36

Nebraska Oncology Society

ASCO 2022 on Moving Toward a Cure in Myeloma: The Role of MRD Testing

FEATURING Ajay Nooka
  • 320 views
  • July 7, 2022
  • 3